Lung Cancer Surgery Market Revenue to Attain USD 2.76 Bn by 2035

Published: 02 Mar 2026

Author: Precedence Research

Share:

Lung Cancer Surgery Market Revenue and Trends 2026 to 2035

The global lung cancer surgery market revenue was valued at USD 1.55 billion in 2025 and is expected to attain around USD 2.76 billion by 2035, growing at a CAGR of 5.95% during forecast period.The market is majorly driven by increasing lung cancer rates due to high smoking rates. Growing focus on early detection of lung cancer and technological advancements to remove tumors with the surgical robotics method are also contributing to the market growth.

What are the Major Driving Factors of the Lung Cancer Surgery Market?

One of the major driving factors of the market includes the growing shift toward minimally invasive surgery to treat lung cancer, early disease detection, excessive tobacco use, and rising smoking rates. The growing geriatric population, which is more susceptible to chronic diseases and critical conditions such as lung cancer, is significantly driving market growth. Increasing adoption of minimally invasive procedures, including video-assisted thoracic surgery (VATS) and robotic-assisted surgery, reflects a major technological shift in lung surgery and encourages more patients to opt for surgical treatment due to improved outcomes. Additionally, supportive reimbursement policies and government-backed improvements in healthcare infrastructure are further accelerating market expansion.

Segment Insights

• By Procedure Type, The lobectomy segment held the largest market share in 2025, as it remains the widely accepted and trusted standard surgical procedure for the treatment of lung cancer among healthcare professionals.
• By Surgical Approach, The open surgery segment held the largest market share in 2025 due to its well-established method to treat crucial surgeries like lung surgery, especially at the last stage of cancer cases.
• By Cancer Type, The non-small cell lung cancer segment held the largest market share, as it represents the most common type of lung cancer, characterized by the uncontrolled growth and proliferation of abnormal cells in lung tissues.
• By Provider Type, The hospitals segment held the largest market share in 2025 due to well-equipped infrastructure and the availability of skilled professionals to treat critical cases of lung cancer with surgery. Moreover, hospitals remain the primary care center, driving the patient pool.

Regional Insights

North America held the largest share of the lung cancer surgery market in 2025, driven by the high incidence of lung cancer, largely associated with long-term smoking habits, and well-established healthcare systems focused on early detection and treatment. The region benefits from technologically advanced healthcare infrastructure that supports complex surgical interventions. At the country level, the U.S. significantly contributes to market growth through favorable healthcare regulations, strong reimbursement frameworks, and continued investment in advanced surgical technologies.

Asia Pacific is projected to grow at the fastest CAGR during the forecast period, driven by increasing awareness programs focused on early lung cancer detection and treatment. Additionally, strong government support through reimbursement policies, particularly for late-stage surgical interventions, is improving patient access to advanced treatment options and contributing to regional market growth.

Lung Cancer Surgery Market Coverage

Recent Development

• In March 2025, a leader in surgical solutions and technologies, Johnson and Johnson MedTech announced regulatory clearance for MONARCH QUEST and latest technological upgrades in MONARCH Navigation technology with AI-powered algorithms for robotically assisted bronchoscopy for lung biopsy procedure.(Source: https://www.jnj.com)

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7863

You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344